Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Empagliflozin (25mg)
Dosage Form : Tablet
Packaging Type :
Packaging : 9*10
Price : ₹617/-
Emplozin 25 Tablet is an antidiabetic medication belonging to the class of Sodium-Glucose Co-Transporter-2 (SGLT2) inhibitors. It is used to manage blood sugar levels in individuals with type 2 diabetes mellitus, particularly when diet and exercise alone are insufficient. By reducing glucose reabsorption in the kidneys, it promotes glucose excretion through urine, helping maintain optimal blood sugar levels. Additionally, Empagliflozin has shown cardiovascular benefits, including reducing the risk of cardiovascular death in patients with type 2 diabetes and established heart disease.
This medication supports better glycemic control, potentially leading to weight loss and lower blood pressure due to its unique mechanism of action. Emplozin 25 Tablet is an effective solution for managing diabetes and its complications under the guidance of a healthcare provider.
Common side effects include urinary tract infections, increased urination, dizziness, and dehydration. Rare but serious side effects include ketoacidosis and severe genital infections.
Emplozin 25 Tablet is indicated for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise. It also reduces the risk of cardiovascular death in patients with type 2 diabetes and cardiovascular disease.
This medication is not suitable for type 1 diabetes or diabetic ketoacidosis. Always follow the prescribed dosage and inform your doctor about any underlying conditions or medications you are taking.
Composition : Gatifloxacin (0.3% w/v)
Composition : Ketorolac (0.4% w/v) + Olopatadine (0.1% w/v)